All Stories

  1. The Transcription Map of Human Papillomavirus Type 18 during Genome Replication in U2OS Cells
  2. Mapping of Betapapillomavirus Human Papillomavirus 5 Transcription and Characterization of Viral-Genome Replication Function
  3. RIG-I and MDA-5 Detection of Viral RNA-dependent RNA Polymerase Activity Restricts Positive-Strand RNA Virus Replication
  4. Recombination-Dependent Oligomerization of Human Papillomavirus Genomes upon Transient DNA Replication
  5. New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids
  6. Engagement of the ATR-Dependent DNA Damage Response at the Human Papillomavirus 18 Replication Centers during the Initial Amplification
  7. 332 The Anti-tyrosinase Monoclonal Antibody is Effective in Treating Mice Bearing Syngenic Melanoma
  8. Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU®-Multi-HIVB, in untreated HIV-1 infected subjects
  9. Identification and Analysis of Papillomavirus E2 Protein Binding Sites in the Human Genome
  10. Development of a Cellular Assay System To Study the Genome Replication of High- and Low-Risk Mucosal and Cutaneous Human Papillomaviruses
  11. Human papillomavirus E2 protein with single activation domain initiates HPV18 genome replication, but is not sufficient for long-term maintenance of virus genome
  12. Effective Formation of the Segregation-Competent Complex Determines Successful Partitioning of the Bovine Papillomavirus Genome during Cell Division
  13. Elicitation of broad CTL response against HIV-1 by the DNA vaccine encoding artificial multi-component fusion protein MultiHIV—Study in domestic pigs
  14. Persistent Immune Responses Induced by a Human Immunodeficiency Virus DNA Vaccine Delivered in Association with Electroporation in the Skin of Nonhuman Primates
  15. P17-11. HIV DNA vaccine delivery in association with electroporation in the skin of nonhuman primates
  16. P19-30. GTU® as beneficial HIV DNA vaccine vector system
  17. Mechanism of Genomic Instability in Cells Infected with the High-Risk Human Papillomaviruses
  18. Bovine papillomavirus type 1 E2 protein heterodimer is functional in papillomavirus DNA replication in vivo
  19. Papillomavirus DNA replication — From initiation to genomic instability
  20. OA05-03. Efficacy study of a T-cell-based DNA vaccine delivered by intradermal electrotransfer in macaques
  21. Functional Characterization of Fingers Subdomain-specific Monoclonal Antibodies Inhibiting the Hepatitis C Virus RNA-dependent RNA Polymerase
  22. CuZn-SOD suppresses the bovine papillomavirus-induced proliferation of fibroblasts
  23. Organization and Expression of the Genome of Bovine Papillomavirus Type 1
  24. Genomic instability of the host cell induced by the human papillomavirus replication machinery
  25. High Prevalence of The CCR5Δ32 HIV-Resistance Mutation among Estonian HIV Type 1-Infected Individuals
  26. Coinfection of Chlamydia trachomatis, Ureaplasma urealyticum and human papillomavirus among patients attending STD clinics in Estonia
  27. Characterization of the Functional Activities of the Bovine Papillomavirus Type 1 E2 Protein Single-Chain Heterodimers
  28. Induction of Human Immunodeficiency Virus Type-1-Specific Immunity with a Novel Gene Transport Unit (GTU)-MultiHIV DNA Vaccine
  29. Complex formation between hepatitis C virus NS2 and NS3 proteins
  30. Brd4 Is Involved in Multiple Processes of the Bovine Papillomavirus Type 1 Life Cycle
  31. WITHDRAWN: Corrigendum to “A DNA HIV-1 vaccine based on a fusion gene expressing non-structural and structural genes of consensus sequence of the A-C subtypes and the ancestor sequence of the F-H subtypes. Preclinical and clinical studies” [Microbes In...
  32. Bovine papillomavirus type 1 oncoprotein E5 stimulates the utilization of superoxide radicals in the mouse fibroblast cell line C127
  33. Episomal Maintenance of Plasmids with Hybrid Origins in Mouse Cells
  34. A DNA HIV-1 vaccine based on a fusion gene expressing non-structural and structural genes of consensus sequence of the A–C subtypes and the ancestor sequence of the F–H subtypes. Preclinical and clinical studies
  35. Association of Bovine Papillomavirus E2 Protein with Nuclear Structures In Vivo
  36. The Properties of the tRNA · protein Complex of the Escherichia coli Ribosome
  37. Analysis of Chromatin Attachment and Partitioning Functions of Bovine Papillomavirus Type 1 E2 Protein
  38. Production of functional recombinant tyrosine hydroxylase by the BPV-1 expression plasmids in the cell cultures
  39. Identification of the immunodominant regions of the melanoma antigen tyrosinase by anti-tyrosinase monoclonal antibodies
  40. Effective generation of transgenic mice by Bovine papillomavirus type 1 based self-replicating plasmid that is maintained as extrachromosomal genetic element in three generations of animals
  41. Induction of the Bovine Papillomavirus Origin “Onion Skin”-Type DNA Replication at High E1 Protein Concentrations In Vivo
  42. Efficient Transfection of Novel Bovine Papillomavirus 1 Expression Plasmids
  43. Roles of the hinge region and the DNA binding domain of the bovine papillomavirus type 1 E2 protein in initiation of DNA replication
  44. Replication of a chimeric origin containing elements from Epstein–Barr virus ori P and bovine papillomavirus minimal origin
  45. Bovine papillomavirus oncoprotein E5 affects the arachidonic acid metabolism in cells
  46. DNA vaccination in mice using HIV-1 nef, rev and tat genes in self-replicating pBN-vector
  47. Diversity of Helicobacter pylori genotypes among Estonian and Russian patients with perforated peptic ulcer, living in Southern Estonia
  48. The Basis of Prostaglandin Synthesis in Coral: MOLECULAR CLONING AND EXPRESSION OF A CYCLOOXYGENASE FROM THE ARCTIC SOFT CORAL GERSEMIA FRUTICOSA
  49. Hepatitis C virus genotypes in EstoniaNote
  50. Cell-Specific Modulation of Papovavirus Replication by Tumor Suppressor Protein p53
  51. Functional Domains of the TOL Plasmid Transcription Factor XylS
  52. Inhibition of the bovine papillomavirus E2 protein activity by peptide nucleic acid
  53. Prevalence of ticks infected with Borrelia burgdorferi in Estonia
  54. Transfection of BPV-LAC Z plasmids in primate CV1-P and SH-SY5Y cell cultures
  55. Opioid antagonist naloxone potentiates anxiogenic-like action of cholecystokinin agonists in elevated plus-maze
  56. Bovine papilomavirus oncoprotein E5 induces the NFκB activation through superoxide radicals
  57. TOL plasmid transcription factor XylS binds specifically to the Pm operator sequence
  58. The bovine papillomavirus origin of replication requires a binding site for the E2 transcriptional activator.
  59. Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins.
  60. Replication of the bovine papillomavirus type 1 genome; antisense transcripts prevent episomal replication
  61. The role of protein L16 and its fragments in the peptidyltransferase activity of 50-S ribosomal subunits
  62. The interaction of ribosomal protein L16 and its fragments with tRNA
  63. 5S RNA-Protein complex is involved in ribosomal subunit association
  64. The Composition and Properties of the Escherichia coli 5-S RNA-Protein Complex
  65. The interaction of 5 S RNA and its large fragments with ribosomal proteins
  66. A quaternary complex consisting of two molecules of tRNA and ribosomal proteins L2 and L17
  67. Cobra venom acetylcholinesterase—II. Substrate specifity
  68. Interaction of 5-S RNA, 5.8-S RNA and tRNA with Rat-Liver Ribosomal Proteins
  69. The domain for transfer ribonucleic acid binding to theEscherichia coliribosome
  70. The interaction of transfer ribonucleic acid with 50 S ribosomal subunit proteins
  71. The interaction of transfer ribonucleic acid with 30 S ribosomal subunit proteins